KK2223

· Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK2223, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma [Phase 1]

See pricing